Clinical Trials Directory

Trials / Completed

CompletedNCT00998998

The Anemia Control Program: Early Intervention

Iron Deficiency Anemia and Infant Behavior: Early Intervention Study II

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
277 (actual)
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NIH
Sex
All
Age
6 Months – 12 Months
Healthy volunteers
Not accepted

Summary

The purpose of this study was to determine if a home-based intervention to foster child development improved behavior and development in infants with IDA.

Detailed description

Iron-deficiency anemia (IDA) is associated with alterations in infant behavior and development that may not correct with iron therapy. The purpose of this study was to determine if a home-based intervention to foster child development improved behavior and development in infants with IDA. IDA and non-anemic infants were randomly assigned to a year of intervention or surveillance only. Infants were enrolled and began study participation at 6 or 12 months. All infants were treated with oral iron and visited weekly to record iron intake, feeding, and health (surveillance). For infants randomized to intervention, the weekly home visit included an hour-long program fostering child development by supporting the mother-infant relationship. Psychologists, unaware of iron status or intervention assignment, assessed cognitive, motor, and social-emotional development (Bayley Scales) at the beginning, midpoint, and end of the year.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHome stimulationWeekly visit of one hour to the home over the course of one year to foster the mother-child relationship.
BEHAVIORALSurveillanceWeekly visits to the home over the course of one year to record iron intake, feeding, and health information.
DIETARY_SUPPLEMENTIronSix-month-old infants treated orally for 1 y with 15 mg elemental Fe/d as ferrous sulfate. Twelve-month old infants treated orally for a minimum of 6 months with 30 mg elemental Fe/d.

Timeline

Start date
1992-04-01
Primary completion
1996-07-01
Completion
1996-07-01
First posted
2009-10-21
Last updated
2010-07-21

Locations

1 site across 1 country: Chile

Source: ClinicalTrials.gov record NCT00998998. Inclusion in this directory is not an endorsement.